Company Filing History:
2 out of 258 
1 out of 389 
1 out of 1,456 
Years Active: 2012-2013
Title: The Innovations of Jesus Benavides
Introduction
Jesus Benavides is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of two patents to his name, his work focuses on innovative compounds that address critical health issues.
Latest Patents
Among his latest patents is the 6-pyrimidinyl-pyrimid-4-one derivative. This compound is represented by the formula (I) or a pharmaceutically acceptable salt thereof. It is utilized for the preventive and/or therapeutic treatment of diseases caused by abnormal activity of tau protein kinase 1, such as neurodegenerative diseases, including Alzheimer’s disease. This innovation highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Jesus Benavides has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Mitsubishi Tanabe Pharma Corporation and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Some of his notable coworkers include Kenji Fukunaga and Kazutoshi Watanabe. Their collaboration has likely played a role in the successful development of his patents and innovations.
Conclusion
Jesus Benavides is a distinguished inventor whose work in pharmaceuticals has the potential to make a significant impact on the treatment of neurodegenerative diseases. His innovative compounds and collaborations reflect his dedication to improving healthcare solutions.